nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—TPMT—Azathioprine—systemic scleroderma	0.49	0.619	CbGbCtD
Cefazolin—SLC22A6—Captopril—systemic scleroderma	0.0539	0.068	CbGbCtD
Cefazolin—ALB—Captopril—systemic scleroderma	0.0459	0.0579	CbGbCtD
Cefazolin—SLC22A11—Methotrexate—systemic scleroderma	0.042	0.053	CbGbCtD
Cefazolin—ABCC4—Methotrexate—systemic scleroderma	0.0391	0.0494	CbGbCtD
Cefazolin—ALB—Mycophenolate mofetil—systemic scleroderma	0.0362	0.0456	CbGbCtD
Cefazolin—ALB—Prednisone—systemic scleroderma	0.0289	0.0365	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—systemic scleroderma	0.0244	0.0308	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—systemic scleroderma	0.017	0.0215	CbGbCtD
Cefazolin—PON1—artery—systemic scleroderma	0.0165	0.46	CbGeAlD
Cefazolin—ALB—Methotrexate—systemic scleroderma	0.0145	0.0183	CbGbCtD
Cefazolin—PON1—blood vessel—systemic scleroderma	0.0129	0.358	CbGeAlD
Cefazolin—SLC22A11—digestive system—systemic scleroderma	0.00153	0.0426	CbGeAlD
Cefazolin—TPMT—tendon—systemic scleroderma	0.00138	0.0384	CbGeAlD
Cefazolin—TPMT—lung—systemic scleroderma	0.00121	0.0337	CbGeAlD
Cefazolin—ABCC4—digestive system—systemic scleroderma	0.000872	0.0242	CbGeAlD
Cefazolin—ABCC4—tendon—systemic scleroderma	0.000829	0.0231	CbGeAlD
Cefazolin—ABCC4—lung—systemic scleroderma	0.000728	0.0202	CbGeAlD
Cefazolin—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000358	0.00209	CcSEcCtD
Cefazolin—Anorexia—Captopril—systemic scleroderma	0.000357	0.00208	CcSEcCtD
Cefazolin—Flatulence—Mycophenolic acid—systemic scleroderma	0.000355	0.00207	CcSEcCtD
Cefazolin—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.000355	0.00207	CcSEcCtD
Cefazolin—Asthenia—Pentoxifylline—systemic scleroderma	0.000354	0.00207	CcSEcCtD
Cefazolin—Erythema multiforme—Lisinopril—systemic scleroderma	0.000353	0.00206	CcSEcCtD
Cefazolin—Hypotension—Captopril—systemic scleroderma	0.00035	0.00204	CcSEcCtD
Cefazolin—Pruritus—Pentoxifylline—systemic scleroderma	0.000349	0.00204	CcSEcCtD
Cefazolin—Anaemia—Leflunomide—systemic scleroderma	0.000349	0.00204	CcSEcCtD
Cefazolin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000348	0.00203	CcSEcCtD
Cefazolin—Vaginal infection—Methotrexate—systemic scleroderma	0.000348	0.00203	CcSEcCtD
Cefazolin—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000346	0.00202	CcSEcCtD
Cefazolin—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00198	CcSEcCtD
Cefazolin—Leukopenia—Leflunomide—systemic scleroderma	0.000338	0.00197	CcSEcCtD
Cefazolin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000338	0.00197	CcSEcCtD
Cefazolin—Abdominal pain—Mometasone—systemic scleroderma	0.000337	0.00196	CcSEcCtD
Cefazolin—Body temperature increased—Mometasone—systemic scleroderma	0.000337	0.00196	CcSEcCtD
Cefazolin—Mouth ulceration—Methotrexate—systemic scleroderma	0.000333	0.00194	CcSEcCtD
Cefazolin—Anaemia—Mycophenolic acid—systemic scleroderma	0.000333	0.00194	CcSEcCtD
Cefazolin—Somnolence—Captopril—systemic scleroderma	0.000333	0.00194	CcSEcCtD
Cefazolin—Agitation—Mycophenolic acid—systemic scleroderma	0.000331	0.00193	CcSEcCtD
Cefazolin—Dyspepsia—Captopril—systemic scleroderma	0.000329	0.00192	CcSEcCtD
Cefazolin—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000329	0.00191	CcSEcCtD
Cefazolin—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00191	CcSEcCtD
Cefazolin—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00191	CcSEcCtD
Cefazolin—Dizziness—Pentoxifylline—systemic scleroderma	0.000327	0.0019	CcSEcCtD
Cefazolin—Decreased appetite—Captopril—systemic scleroderma	0.000325	0.0019	CcSEcCtD
Cefazolin—Syncope—Mycophenolic acid—systemic scleroderma	0.000323	0.00188	CcSEcCtD
Cefazolin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000323	0.00188	CcSEcCtD
Cefazolin—Fatigue—Captopril—systemic scleroderma	0.000323	0.00188	CcSEcCtD
Cefazolin—Flatulence—Lisinopril—systemic scleroderma	0.00032	0.00187	CcSEcCtD
Cefazolin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00032	0.00186	CcSEcCtD
Cefazolin—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000317	0.00185	CcSEcCtD
Cefazolin—Vomiting—Pentoxifylline—systemic scleroderma	0.000314	0.00183	CcSEcCtD
Cefazolin—Convulsion—Mycophenolic acid—systemic scleroderma	0.000312	0.00182	CcSEcCtD
Cefazolin—Rash—Pentoxifylline—systemic scleroderma	0.000311	0.00181	CcSEcCtD
Cefazolin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000311	0.00181	CcSEcCtD
Cefazolin—Headache—Pentoxifylline—systemic scleroderma	0.000309	0.0018	CcSEcCtD
Cefazolin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000308	0.0018	CcSEcCtD
Cefazolin—Feeling abnormal—Captopril—systemic scleroderma	0.000308	0.0018	CcSEcCtD
Cefazolin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000306	0.00178	CcSEcCtD
Cefazolin—Asthenia—Mometasone—systemic scleroderma	0.000306	0.00178	CcSEcCtD
Cefazolin—Hypotension—Azathioprine—systemic scleroderma	0.000305	0.00178	CcSEcCtD
Cefazolin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000302	0.00176	CcSEcCtD
Cefazolin—Pruritus—Mometasone—systemic scleroderma	0.000302	0.00176	CcSEcCtD
Cefazolin—Anaemia—Lisinopril—systemic scleroderma	0.0003	0.00175	CcSEcCtD
Cefazolin—Confusional state—Mycophenolic acid—systemic scleroderma	0.000297	0.00173	CcSEcCtD
Cefazolin—Abdominal pain—Captopril—systemic scleroderma	0.000296	0.00172	CcSEcCtD
Cefazolin—Body temperature increased—Captopril—systemic scleroderma	0.000296	0.00172	CcSEcCtD
Cefazolin—Anorexia—Leflunomide—systemic scleroderma	0.000294	0.00171	CcSEcCtD
Cefazolin—Nausea—Pentoxifylline—systemic scleroderma	0.000293	0.00171	CcSEcCtD
Cefazolin—Diarrhoea—Mometasone—systemic scleroderma	0.000292	0.0017	CcSEcCtD
Cefazolin—Syncope—Lisinopril—systemic scleroderma	0.000291	0.0017	CcSEcCtD
Cefazolin—Leukopenia—Lisinopril—systemic scleroderma	0.000291	0.00169	CcSEcCtD
Cefazolin—Shock—Mycophenolic acid—systemic scleroderma	0.00029	0.00169	CcSEcCtD
Cefazolin—Hypotension—Leflunomide—systemic scleroderma	0.000288	0.00168	CcSEcCtD
Cefazolin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000288	0.00168	CcSEcCtD
Cefazolin—Loss of consciousness—Lisinopril—systemic scleroderma	0.000285	0.00166	CcSEcCtD
Cefazolin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000281	0.00163	CcSEcCtD
Cefazolin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00163	CcSEcCtD
Cefazolin—Hypotension—Mycophenolic acid—systemic scleroderma	0.000275	0.0016	CcSEcCtD
Cefazolin—Dyspepsia—Leflunomide—systemic scleroderma	0.000272	0.00158	CcSEcCtD
Cefazolin—Vomiting—Mometasone—systemic scleroderma	0.000271	0.00158	CcSEcCtD
Cefazolin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000269	0.00157	CcSEcCtD
Cefazolin—Rash—Mometasone—systemic scleroderma	0.000269	0.00157	CcSEcCtD
Cefazolin—Asthenia—Captopril—systemic scleroderma	0.000269	0.00157	CcSEcCtD
Cefazolin—Dermatitis—Mometasone—systemic scleroderma	0.000268	0.00156	CcSEcCtD
Cefazolin—Decreased appetite—Leflunomide—systemic scleroderma	0.000268	0.00156	CcSEcCtD
Cefazolin—Confusional state—Lisinopril—systemic scleroderma	0.000267	0.00156	CcSEcCtD
Cefazolin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000267	0.00156	CcSEcCtD
Cefazolin—Headache—Mometasone—systemic scleroderma	0.000267	0.00156	CcSEcCtD
Cefazolin—Fatigue—Leflunomide—systemic scleroderma	0.000266	0.00155	CcSEcCtD
Cefazolin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000265	0.00154	CcSEcCtD
Cefazolin—Pruritus—Captopril—systemic scleroderma	0.000265	0.00154	CcSEcCtD
Cefazolin—Pain—Leflunomide—systemic scleroderma	0.000264	0.00154	CcSEcCtD
Cefazolin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00153	CcSEcCtD
Cefazolin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000262	0.00152	CcSEcCtD
Cefazolin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00152	CcSEcCtD
Cefazolin—Shock—Lisinopril—systemic scleroderma	0.000261	0.00152	CcSEcCtD
Cefazolin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00026	0.00151	CcSEcCtD
Cefazolin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000259	0.00151	CcSEcCtD
Cefazolin—Neutropenia—Prednisone—systemic scleroderma	0.000259	0.00151	CcSEcCtD
Cefazolin—Abdominal pain—Azathioprine—systemic scleroderma	0.000258	0.00151	CcSEcCtD
Cefazolin—Body temperature increased—Azathioprine—systemic scleroderma	0.000258	0.00151	CcSEcCtD
Cefazolin—Diarrhoea—Captopril—systemic scleroderma	0.000256	0.00149	CcSEcCtD
Cefazolin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000256	0.00149	CcSEcCtD
Cefazolin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00149	CcSEcCtD
Cefazolin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00148	CcSEcCtD
Cefazolin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000254	0.00148	CcSEcCtD
Cefazolin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000254	0.00148	CcSEcCtD
Cefazolin—Nausea—Mometasone—systemic scleroderma	0.000253	0.00148	CcSEcCtD
Cefazolin—Anorexia—Lisinopril—systemic scleroderma	0.000253	0.00147	CcSEcCtD
Cefazolin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000252	0.00147	CcSEcCtD
Cefazolin—Pain—Mycophenolic acid—systemic scleroderma	0.000252	0.00147	CcSEcCtD
Cefazolin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00025	0.00146	CcSEcCtD
Cefazolin—Hypotension—Lisinopril—systemic scleroderma	0.000248	0.00144	CcSEcCtD
Cefazolin—Dizziness—Captopril—systemic scleroderma	0.000248	0.00144	CcSEcCtD
Cefazolin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00144	CcSEcCtD
Cefazolin—Urticaria—Leflunomide—systemic scleroderma	0.000245	0.00143	CcSEcCtD
Cefazolin—Abdominal pain—Leflunomide—systemic scleroderma	0.000244	0.00142	CcSEcCtD
Cefazolin—Body temperature increased—Leflunomide—systemic scleroderma	0.000244	0.00142	CcSEcCtD
Cefazolin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000243	0.00141	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000241	0.0014	CcSEcCtD
Cefazolin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000241	0.0014	CcSEcCtD
Cefazolin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000241	0.0014	CcSEcCtD
Cefazolin—Vomiting—Captopril—systemic scleroderma	0.000238	0.00139	CcSEcCtD
Cefazolin—Rash—Captopril—systemic scleroderma	0.000236	0.00138	CcSEcCtD
Cefazolin—Dermatitis—Captopril—systemic scleroderma	0.000236	0.00137	CcSEcCtD
Cefazolin—Somnolence—Lisinopril—systemic scleroderma	0.000236	0.00137	CcSEcCtD
Cefazolin—Headache—Captopril—systemic scleroderma	0.000234	0.00137	CcSEcCtD
Cefazolin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000234	0.00136	CcSEcCtD
Cefazolin—Dyspepsia—Lisinopril—systemic scleroderma	0.000233	0.00136	CcSEcCtD
Cefazolin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000233	0.00136	CcSEcCtD
Cefazolin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000233	0.00136	CcSEcCtD
Cefazolin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000232	0.00135	CcSEcCtD
Cefazolin—Decreased appetite—Lisinopril—systemic scleroderma	0.00023	0.00134	CcSEcCtD
Cefazolin—Eosinophilia—Methotrexate—systemic scleroderma	0.000229	0.00134	CcSEcCtD
Cefazolin—Fatigue—Lisinopril—systemic scleroderma	0.000229	0.00133	CcSEcCtD
Cefazolin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00133	CcSEcCtD
Cefazolin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00133	CcSEcCtD
Cefazolin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000227	0.00132	CcSEcCtD
Cefazolin—Pain—Lisinopril—systemic scleroderma	0.000227	0.00132	CcSEcCtD
Cefazolin—Diarrhoea—Azathioprine—systemic scleroderma	0.000224	0.0013	CcSEcCtD
Cefazolin—Haemoglobin—Prednisone—systemic scleroderma	0.000223	0.0013	CcSEcCtD
Cefazolin—Nausea—Captopril—systemic scleroderma	0.000222	0.0013	CcSEcCtD
Cefazolin—Haemorrhage—Prednisone—systemic scleroderma	0.000222	0.00129	CcSEcCtD
Cefazolin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00129	CcSEcCtD
Cefazolin—Asthenia—Leflunomide—systemic scleroderma	0.000221	0.00129	CcSEcCtD
Cefazolin—Pancytopenia—Methotrexate—systemic scleroderma	0.00022	0.00128	CcSEcCtD
Cefazolin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000218	0.00127	CcSEcCtD
Cefazolin—Pruritus—Leflunomide—systemic scleroderma	0.000218	0.00127	CcSEcCtD
Cefazolin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00126	CcSEcCtD
Cefazolin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000217	0.00126	CcSEcCtD
Cefazolin—Neutropenia—Methotrexate—systemic scleroderma	0.000216	0.00126	CcSEcCtD
Cefazolin—Dizziness—Azathioprine—systemic scleroderma	0.000216	0.00126	CcSEcCtD
Cefazolin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000211	0.00123	CcSEcCtD
Cefazolin—Diarrhoea—Leflunomide—systemic scleroderma	0.000211	0.00123	CcSEcCtD
Cefazolin—Urticaria—Lisinopril—systemic scleroderma	0.000211	0.00123	CcSEcCtD
Cefazolin—Abdominal pain—Lisinopril—systemic scleroderma	0.00021	0.00122	CcSEcCtD
Cefazolin—Body temperature increased—Lisinopril—systemic scleroderma	0.00021	0.00122	CcSEcCtD
Cefazolin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000208	0.00121	CcSEcCtD
Cefazolin—Vomiting—Azathioprine—systemic scleroderma	0.000208	0.00121	CcSEcCtD
Cefazolin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000206	0.0012	CcSEcCtD
Cefazolin—Rash—Azathioprine—systemic scleroderma	0.000206	0.0012	CcSEcCtD
Cefazolin—Dermatitis—Azathioprine—systemic scleroderma	0.000206	0.0012	CcSEcCtD
Cefazolin—Headache—Azathioprine—systemic scleroderma	0.000205	0.00119	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000205	0.00119	CcSEcCtD
Cefazolin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00119	CcSEcCtD
Cefazolin—Dizziness—Leflunomide—systemic scleroderma	0.000204	0.00119	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—systemic scleroderma	0.000203	0.00118	CcSEcCtD
Cefazolin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000202	0.00118	CcSEcCtD
Cefazolin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000201	0.00117	CcSEcCtD
Cefazolin—Stomatitis—Methotrexate—systemic scleroderma	0.000201	0.00117	CcSEcCtD
Cefazolin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00116	CcSEcCtD
Cefazolin—Vomiting—Leflunomide—systemic scleroderma	0.000196	0.00114	CcSEcCtD
Cefazolin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000195	0.00114	CcSEcCtD
Cefazolin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000195	0.00113	CcSEcCtD
Cefazolin—Rash—Leflunomide—systemic scleroderma	0.000195	0.00113	CcSEcCtD
Cefazolin—Dermatitis—Leflunomide—systemic scleroderma	0.000194	0.00113	CcSEcCtD
Cefazolin—Nausea—Azathioprine—systemic scleroderma	0.000194	0.00113	CcSEcCtD
Cefazolin—Headache—Leflunomide—systemic scleroderma	0.000193	0.00113	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000193	0.00112	CcSEcCtD
Cefazolin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00112	CcSEcCtD
Cefazolin—Asthenia—Lisinopril—systemic scleroderma	0.00019	0.00111	CcSEcCtD
Cefazolin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00019	0.00111	CcSEcCtD
Cefazolin—Pruritus—Lisinopril—systemic scleroderma	0.000188	0.00109	CcSEcCtD
Cefazolin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000187	0.00109	CcSEcCtD
Cefazolin—Haemoglobin—Methotrexate—systemic scleroderma	0.000186	0.00108	CcSEcCtD
Cefazolin—Rash—Mycophenolic acid—systemic scleroderma	0.000186	0.00108	CcSEcCtD
Cefazolin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000185	0.00108	CcSEcCtD
Cefazolin—Haemorrhage—Methotrexate—systemic scleroderma	0.000185	0.00108	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—systemic scleroderma	0.000185	0.00108	CcSEcCtD
Cefazolin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00108	CcSEcCtD
Cefazolin—Headache—Mycophenolic acid—systemic scleroderma	0.000184	0.00107	CcSEcCtD
Cefazolin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00107	CcSEcCtD
Cefazolin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00107	CcSEcCtD
Cefazolin—Nausea—Leflunomide—systemic scleroderma	0.000183	0.00107	CcSEcCtD
Cefazolin—Diarrhoea—Lisinopril—systemic scleroderma	0.000181	0.00106	CcSEcCtD
Cefazolin—Anaemia—Prednisone—systemic scleroderma	0.000178	0.00104	CcSEcCtD
Cefazolin—Agitation—Prednisone—systemic scleroderma	0.000177	0.00103	CcSEcCtD
Cefazolin—Dizziness—Lisinopril—systemic scleroderma	0.000175	0.00102	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000175	0.00102	CcSEcCtD
Cefazolin—Nausea—Mycophenolic acid—systemic scleroderma	0.000175	0.00102	CcSEcCtD
Cefazolin—Syncope—Prednisone—systemic scleroderma	0.000173	0.00101	CcSEcCtD
Cefazolin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000997	CcSEcCtD
Cefazolin—Loss of consciousness—Prednisone—systemic scleroderma	0.00017	0.000988	CcSEcCtD
Cefazolin—Vomiting—Lisinopril—systemic scleroderma	0.000169	0.000982	CcSEcCtD
Cefazolin—Rash—Lisinopril—systemic scleroderma	0.000167	0.000974	CcSEcCtD
Cefazolin—Convulsion—Prednisone—systemic scleroderma	0.000167	0.000974	CcSEcCtD
Cefazolin—Dermatitis—Lisinopril—systemic scleroderma	0.000167	0.000973	CcSEcCtD
Cefazolin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000971	CcSEcCtD
Cefazolin—Headache—Lisinopril—systemic scleroderma	0.000166	0.000968	CcSEcCtD
Cefazolin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000958	CcSEcCtD
Cefazolin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000926	CcSEcCtD
Cefazolin—Nausea—Lisinopril—systemic scleroderma	0.000157	0.000918	CcSEcCtD
Cefazolin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000157	0.000918	CcSEcCtD
Cefazolin—Shock—Prednisone—systemic scleroderma	0.000155	0.000903	CcSEcCtD
Cefazolin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000895	CcSEcCtD
Cefazolin—Anorexia—Prednisone—systemic scleroderma	0.00015	0.000875	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—systemic scleroderma	0.000149	0.000868	CcSEcCtD
Cefazolin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000861	CcSEcCtD
Cefazolin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000853	CcSEcCtD
Cefazolin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000853	CcSEcCtD
Cefazolin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000848	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—systemic scleroderma	0.000144	0.000841	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—systemic scleroderma	0.00014	0.000814	CcSEcCtD
Cefazolin—Dyspepsia—Prednisone—systemic scleroderma	0.000139	0.000808	CcSEcCtD
Cefazolin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000804	CcSEcCtD
Cefazolin—Decreased appetite—Prednisone—systemic scleroderma	0.000137	0.000798	CcSEcCtD
Cefazolin—Fatigue—Prednisone—systemic scleroderma	0.000136	0.000791	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—systemic scleroderma	0.000133	0.000773	CcSEcCtD
Cefazolin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000132	0.000767	CcSEcCtD
Cefazolin—Feeling abnormal—Prednisone—systemic scleroderma	0.00013	0.000756	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000129	0.000751	CcSEcCtD
Cefazolin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000129	0.00075	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—systemic scleroderma	0.000125	0.000731	CcSEcCtD
Cefazolin—Urticaria—Prednisone—systemic scleroderma	0.000125	0.000729	CcSEcCtD
Cefazolin—Abdominal pain—Prednisone—systemic scleroderma	0.000124	0.000725	CcSEcCtD
Cefazolin—Body temperature increased—Prednisone—systemic scleroderma	0.000124	0.000725	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—systemic scleroderma	0.000123	0.000717	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—systemic scleroderma	0.000117	0.000682	CcSEcCtD
Cefazolin—Hypersensitivity—Prednisone—systemic scleroderma	0.000116	0.000676	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—systemic scleroderma	0.000116	0.000675	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—systemic scleroderma	0.000114	0.000667	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—systemic scleroderma	0.000113	0.000661	CcSEcCtD
Cefazolin—Asthenia—Prednisone—systemic scleroderma	0.000113	0.000658	CcSEcCtD
Cefazolin—Pain—Methotrexate—systemic scleroderma	0.000113	0.000656	CcSEcCtD
Cefazolin—Pruritus—Prednisone—systemic scleroderma	0.000111	0.000649	CcSEcCtD
Cefazolin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000108	0.000632	CcSEcCtD
Cefazolin—Diarrhoea—Prednisone—systemic scleroderma	0.000108	0.000628	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000108	0.000627	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—systemic scleroderma	0.000105	0.000609	CcSEcCtD
Cefazolin—Dizziness—Prednisone—systemic scleroderma	0.000104	0.000607	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—systemic scleroderma	0.000104	0.000606	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—systemic scleroderma	0.000104	0.000606	CcSEcCtD
Cefazolin—Vomiting—Prednisone—systemic scleroderma	0.0001	0.000583	CcSEcCtD
Cefazolin—Rash—Prednisone—systemic scleroderma	9.93e-05	0.000579	CcSEcCtD
Cefazolin—Dermatitis—Prednisone—systemic scleroderma	9.92e-05	0.000578	CcSEcCtD
Cefazolin—Headache—Prednisone—systemic scleroderma	9.86e-05	0.000575	CcSEcCtD
Cefazolin—Hypersensitivity—Methotrexate—systemic scleroderma	9.69e-05	0.000565	CcSEcCtD
Cefazolin—Asthenia—Methotrexate—systemic scleroderma	9.44e-05	0.00055	CcSEcCtD
Cefazolin—Nausea—Prednisone—systemic scleroderma	9.35e-05	0.000545	CcSEcCtD
Cefazolin—Pruritus—Methotrexate—systemic scleroderma	9.31e-05	0.000543	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—systemic scleroderma	9e-05	0.000525	CcSEcCtD
Cefazolin—Dizziness—Methotrexate—systemic scleroderma	8.7e-05	0.000507	CcSEcCtD
Cefazolin—Vomiting—Methotrexate—systemic scleroderma	8.37e-05	0.000488	CcSEcCtD
Cefazolin—Rash—Methotrexate—systemic scleroderma	8.3e-05	0.000483	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—systemic scleroderma	8.29e-05	0.000483	CcSEcCtD
Cefazolin—Headache—Methotrexate—systemic scleroderma	8.24e-05	0.00048	CcSEcCtD
Cefazolin—Nausea—Methotrexate—systemic scleroderma	7.82e-05	0.000455	CcSEcCtD
